Literature DB >> 2014304

Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients.

K K Kopecky1, E M Braunstein, K D Brandt, R S Filo, S B Leapman, W N Capello, E C Klatte.   

Abstract

The sensitivity of magnetic resonance (MR) imaging in the detection of avascular necrosis (AVN) of the hip and natural history of the MR findings were determined prospectively in renal allograft recipients, a group at risk for development of the disease. One hundred four patients were studied up to 24 months after transplantation. In 25 hips in 14 patients, MR findings were consistent with AVN. Pain developed in seven hips in four patients; in each hip, the MR images showed abnormality before the onset of symptoms. Plain radiographs showed abnormality in all hips that became painful; however, the plain radiographs of 17 of 18 asymptomatic hips in which MR imaging showed evidence of AVN showed no abnormality over a mean follow-up period of 16 months. All MR lesions in the symptomatic hips were larger than those in the asymptomatic cohort. MR lesions in seven hips (in five asymptomatic patients) regressed in size; in six hips, the MR images returned to normal. The findings suggest that some patients with MR evidence of AVN of the hip have spontaneous improvement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014304     DOI: 10.1148/radiology.179.2.2014304

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  In brief: Ficat classification: avascular necrosis of the femoral head.

Authors:  Muhammad Umar Jawad; Abdul Ahad Haleem; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

2.  Untreated asymptomatic hips in patients with osteonecrosis of the femoral head.

Authors:  Byung-Woo Min; Kwang-Soon Song; Chul-Hyun Cho; Sung-Moon Lee; Kyung-Jae Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-08       Impact factor: 4.176

3.  Repair in osteonecrosis of the femoral head: MR imaging features at long-term follow-up.

Authors:  Masaki Takao; Takashi Nishii; Takashi Sakai; Hideki Yoshikawa; Nobuhiko Sugano
Journal:  Clin Rheumatol       Date:  2010-03-16       Impact factor: 2.980

4.  The prevalence and natural history of early osteonecrosis (ON) of the femoral head.

Authors:  B D Mulliken; D L Renfrew; R A Brand; C G Whitten
Journal:  Iowa Orthop J       Date:  1994

5.  Case report: imaging features in a renal transplant patient with calcineurin inhibitor-induced pain syndrome (CIPS).

Authors:  Russell W Chapin; Elizabeth Chua; Jennifer Simmons; Martin Bunke
Journal:  Skeletal Radiol       Date:  2013-04-25       Impact factor: 2.199

6.  Contrast-enhanced fat saturation magnetic resonance imaging for studying the pathophysiology of osteonecrosis of the hips.

Authors:  K C Li; P Hiette
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

7.  Rapid resolution of femoral head osteonecrosis after rotational acetabular osteotomy.

Authors:  Masahiko Nozawa; Keiji Matsuda; Katsuhiko Maezawa; Sungon Kim; Kouichi Maeda; Takashi Ikegami; Reiko Kubota; Kentaro Hayashi; Masataka Nagayama; Haruka Kaneko
Journal:  J Orthop Traumatol       Date:  2008-10-25

8.  Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients.

Authors:  Masaki Takao; Takashi Sakai; Takashi Nishii; Hideki Yoshikawa; Shiro Takahara; Nobuhiko Sugano
Journal:  Rheumatol Int       Date:  2009-10-28       Impact factor: 2.631

9.  Osteonecrosis in kidney recipients: has hypocalcaemia a role?

Authors:  Alia Mohamed Atallah; Mohamed E Abou El-Ghar; Mohamed A Ghoneim
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

10.  Lesion size changes in osteonecrosis of the femoral head: a long-term prospective study using MRI.

Authors:  Feng-chao Zhao; Zi-rong Li; Nian-fei Zhang; Bai-liang Wang; Wei Sun; Li-ming Cheng; Zhao-hui Liu
Journal:  Int Orthop       Date:  2009-06-17       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.